Рус Eng
The National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, founded in 1891, is one of the world’s leading research institutes in its area.
The center possesses a unique collection of viruses, and has its own vaccine production line. The N.F. Gamaleya Center has successfully engineered and registered two vaccines for the Ebola fever using adenovirus vectors. Read more
Latest news and events
November 9, 2020 changes in structure of scientific departments
October 30, 2020 changes in the staff of Dissertation Committees
October 12, 2020 Y. Y. Chernoryzh’s candidate dissertation defense
October 9, 2020 N. Y. Bondareva’s candidate dissertation defense
October 1, 2020 changes in structure of scientific departments
September 4, 2020 Publication in The Lancet journal
August 27, 2020 Credits for the vaccine
View all
Media about us
December 31, 2020 FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Russian Ministry of Health confirms its readiness for active public relations. Read more
October 13, 2020 Министерство здравоохранения Российской Федерации выдало разрешение на проведение клинического исследования вакцины против коронавирусной инфекции у добровольцев в возрасте старше 60 лет.. Read more
October 5, 2020 Беседу директора центра академика РАН А.Л.Гинцбурга с Владимиром Познером смотрите в эфире Первого канала 5 октября 2020 г..
October 2, 2020 Интервью директора центра академика РАН А.Л.Гинцбурга «Они запустили Спутник» читайте в «Российской Газете» от 2 октября 2020 г..
View all
View all
View all
A tried-and-true technology using vectors that incorporate human adenoviruses

The use of adenovirus vector technology for vector vaccines has been gaining momentum since the 1980s, and is safe and effective, which has been proven in multiple studies.

Read more
The first registered vaccine against COVID-19

On 11 August, the Russian Federation Ministry of Health issued a certificate of registration with the number LP-006395 for a vaccine to help prevent the novel coronavirus infection COVID-19, developed by the Russian Ministry of Health N.F. Gamaleya National Research Center for Epidemiology and Microbiology.

Read more
Gamaleya Ebola vaccine

In December 2015, the Russian Ministry of Health registered the first 2 domestically-produced vaccines against the Ebola hemorrhagic fever. Both these vaccines were engineered at the Russian Ministry of Health N.F. Gamaleya Federal Scientific Research Center of Epidemiology and Microbiology, and passed jointly held preclinical trials, and clinical trials, at institutions run by the Russian Ministry of Health and Ministry of Defense.

Read more